-
NASDAQ Gainers: Susquehanna Bancshares (NASDAQ:SUSQ), Orexigen Therapeutics (NASDAQ:OREX), Viggle Inc. (NASDAQ:VGGL), Caesars Entertainment Corporation (NASDAQ:CZR), Allscripts Healthcare Solutions (NASDAQ:MDRX)
On November 12, 2014, Susquehanna Bancshares, Inc. (NASDAQ:SUSQ) and BB&T announced that they had entered into a definitive merger agreement. Under the terms of the agreement, Susquehanna shareholders will receive $4.05 in cash and 0.253 BB&T shares for each Susquehanna share they own. The merger consideration is currently valued at $13.50 per share; however Susquehanna…
-
Mid Cap Gainers: Susquehanna Bancshares (NASDAQ:SUSQ), J C Penney Company Inc (NYSE:JCP), American Eagle Outfitters (NYSE:AEO), Allscripts Healthcare Solutions (NASDAQ:MDRX), FOSL
BB&T Corporation and Susquehanna Bancshares Inc. (NASDAQ:SUSQ) announced the signing of a definitive agreement under which BB&T will acquire Susquehanna in a cash and stock transaction for total consideration valued at approximately $2.5 billion. This acquisition will significantly expand BB&T’s footprint in the Mid-Atlantic region and improve its ranking to #5 in Maryland. Susquehanna Bancshares,…
-
Stocks in Focus: Susquehanna Bancshares (NASDAQ:SUSQ), Wal-Mart Stores Inc. (NYSE:WMT), Chesapeake Energy Corporation (NYSE:CHK), Baker Hughes Incorporated (NYSE:BHI), ACADIA Pharmaceuticals (NASDAQ:ACAD)
Susquehanna Bancshares, Inc. (NASDAQ:SUSQ) announced Wednesday morning that it agreed to be acquired by BB&T Corp in a cash and stock transaction valued at approximately $2.5 billion. Susquehanna Bancshares, Inc. (NASDAQ:SUSQ) in last trading activity advanced 32.53% to close at $13.12. Company weekly performance is 34.98% while its quarterly performance stands at 29.77%. Susquehanna Bancshares,…
-
Small Cap Losers: Boulder Brands(NASDAQ:BDBD), Susquehanna Bancshares(NASDAQ:SUSQ), Ultratech(NASDAQ:UTEK), Air Methods Corp. (NASDAQ:AIRM), Proto Labs(NYSE:PRLB)
Boulder Brands Inc. (NASDAQ:BDBD) a producer of health products, disclosed that it expected earnings per share (EPS) of approximately $0.08, below the earlier guidance of $0.10-0.12. The company also revealed that it expects quarterly revenue of $133.90 million, an increase of 13% year-over-year (YoY). Analysts polled on Bloomberg had expected the company to report quarterly…